Publicacións en colaboración con investigadores/as de University of Virginia (18)

2024

  1. Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)

    Blood cancer discovery, Vol. 5, Núm. 1, pp. 21-33

2023

  1. Alternative approaches for creating a wealth index: The case of Mozambique

    BMJ Global Health, Vol. 8, Núm. 8

  2. BOHEMIA a cluster randomized trial to assess the impact of an endectocide-based one health approach to malaria in Mozambique: baseline demographics and key malaria indicators

    Malaria Journal, Vol. 22, Núm. 1

  3. BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa—a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings

    Trials, Vol. 24, Núm. 1

  4. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

    Leukemia

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Potential impact of 5 years of ivermectin mass drug administration on malaria outcomes in high burden countries

    BMJ Global Health, Vol. 6, Núm. 11

2019

  1. Adjuvant chemoradiation in pancreatic cancer: Impact of radiotherapy dose on survival

    BMC Cancer, Vol. 19, Núm. 1

  2. Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis

    Translational Oncology, Vol. 12, Núm. 1, pp. 1-7

2018

  1. Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials

    JAMA Ophthalmology, Vol. 136, Núm. 6, pp. 666-677

2016

  1. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: A single-arm, multicentre, phase 2 trial

    The Lancet, Vol. 387, Núm. 10031, pp. 1909-1920

2015

  1. Adjuvant chemoradiation in pancreatic cancer: A pooled analysis in elderly (≥75 years) patients

    Anticancer Research, Vol. 35, Núm. 6, pp. 3441-3446

2014

  1. Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 90, Núm. 4, pp. 911-917

2011

  1. Exposure to Traffic and Risk of Hospitalization Due to Injuries

    Risk Analysis, Vol. 31, Núm. 3, pp. 466-474

2009

  1. IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome

    Journal of Cell Biology, Vol. 187, Núm. 7, pp. 1083-1099

1998

  1. Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions

    Journal of Clinical Investigation, Vol. 102, Núm. 6, pp. 1239-1248

1993

  1. Brain-derived neurotrophic factor and neurotrophin-3 support the survival and neuritogenesis response of developing cochleovestibular ganglion neurons

    Developmental Biology, Vol. 159, Núm. 1, pp. 266-275

1991

  1. Glycosyl-phosphatidylmpsitol/Hiositol phosphoglycan: A signaling system for the low-affinity nerve growth factor receptor

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 88, Núm. 18, pp. 8016-8019